Stoke Therapeutics Inc (STOK) returns
Stoke Therapeutics returns over 5 years
$1,000 invested in Stoke Therapeutics five years ago was worth $1,152 at the close on October 30, 2026, with dividends reinvested: an average return of 2.9% a year. The same $1,000 in the S&P 500 (SPY) became $1,760.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | +1.1% | — | $1,011 | -0.9% |
| 3 months | -12.5% | — | $875.17 | +2.1% |
| Year to date | -17.2% | — | $828.29 | +11.7% |
| 1 year | -17.1% | — | $829.34 | +12.4% |
| 3 years | +636.4% | +94.6% | $7,364 | +88.5% |
| 5 years | +15.2% | +2.9% | $1,152 | +76.0% |
Stoke Therapeutics return by calendar year
| Year | STOK | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -17.2% | +11.7% | -28.9% |
| 2025 | +187.8% | +17.7% | +170.0% |
| 2024 | +109.7% | +24.9% | +84.8% |
| 2023 | -43.0% | +26.2% | -69.2% |
| 2022 | -61.5% | -18.2% | -43.4% |
| 2021 | -61.3% | +28.7% | -90.0% |
| 2020 | +118.7% | +18.4% | +100.3% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: STOK financials
No forecast, no recommendation. This page describes Stoke Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.